Vanguard Group’s HANSEN MEDICAL, INC. COM NEW HNSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-345,007
Closed -$1.37M – 4169
2016
Q2
$1.37M Buy
345,007
+37,091
+12% +$141K ﹤0.01% 3513
2016
Q1
$804K Buy
307,916
+49,898
+19% +$119K ﹤0.01% 3658
2015
Q4
$601K Buy
258,018
+29,100
+13% +$95.1K ﹤0.01% 3783
2015
Q3
$861K Buy
228,918
+3,207
+1% +$21K ﹤0.01% 3679
2015
Q2
$2.06M Buy
225,711
+825
+0.4% +$7.52K ﹤0.01% 3409
2015
Q1
$1.96M Buy
224,886
+27,880
+14% +$227K ﹤0.01% 3426
2014
Q4
$1.09M Buy
197,006
+2,055
+1% +$17K ﹤0.01% 3502
2014
Q3
$2.3M Buy
194,951
+23,003
+13% +$278K ﹤0.01% 3207
2014
Q2
$2.25M Buy
171,948
+6,210
+4% +$108K ﹤0.01% 3220
2014
Q1
$4.31M Buy
165,738
+51,737
+45% +$1.16M ﹤0.01% 2907
2013
Q4
$1.97M Sell
114,001
-17,263
-13% -$320K ﹤0.01% 3190
2013
Q3
$2.35M Buy
131,264
+11,624
+10% +$183K ﹤0.01% 3076
2013
Q2
$1.72M Buy
+119,640
New +$2.12M ﹤0.01% 3123

Vanguard Group's HNSN Position: Q3 2016 in Review

Vanguard Group sold out of HANSEN MEDICAL, INC. COM NEW (HNSN) in Q3 2016, closing a stake of 345,007 shares — an estimated $1.37M sold.

Vanguard Group first reported a position in HNSN in Q2 2013 and held it in 13 quarters. The position peaked at $4.31M in Q1 2014. 0 funds tracked by Wall St. Rank hold HNSN as of Q3 2016.

  • Vanguard Group reported no remaining HANSEN MEDICAL, INC. COM NEW position as of Q3 2016 after selling out during the quarter.
  • Vanguard Group sold 345,007 HANSEN MEDICAL, INC. COM NEW shares in Q3 2016, an estimated $1.37M.
  • Vanguard Group first reported a position in HANSEN MEDICAL, INC. COM NEW in Q2 2013 and held it in 13 quarters.
  • Vanguard Group's HANSEN MEDICAL, INC. COM NEW position peaked at $4.31M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HANSEN MEDICAL, INC. COM NEW as of Q3 2016.

Based on Vanguard Group's 13F filing for Q3 2016, filed 14 Nov 2016.